D46.Z
Other myelodysplastic syndromes
Clinical Classification Guidelines
Excludes Type 1
- chronic myelomonocytic leukemia (C93.1-)
Medical Intelligence & Overview
Other myelodysplastic syndromes (MDS) classified under ICD-10 code D46.Z refer to a group of diverse blood disorders characterized by ineffective blood cell production in the bone marrow. These conditions can lead to abnormal blood cell counts and increase the risk of developing leukemia. While they share some features with other forms of MDS, these syndromes are distinguished by their specific patterns and presentations, often requiring detailed diagnostic evaluation.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting blood cell development History of exposure to certain chemicals, such as benzene Previous chemotherapy or radiation therapy Certain inherited genetic disorders Environmental exposures and lifestyle factors
Key Symptoms: Fatigue and weakness Shortness of breath Unusual bleeding or bruising Frequent infections Pale skin Petechiae (small red or purple spots on the skin) Unintentional weight loss
Diagnostic & Treatment
Diagnosis Path: Complete blood count (CBC) to evaluate blood cell levels Bone marrow biopsy and aspiration to analyze cell morphology Cytogenetic analysis to detect chromosomal abnormalities Molecular testing for specific genetic mutations Additional laboratory tests to rule out other causes of blood cell deficiencies
Treatment Protocols: Supportive care, such as blood transfusions and growth factors Chemotherapy to reduce abnormal cell production Immunomodulatory drugs (e.g., lenalidomide) Hypomethylating agents to modify gene expression Bone marrow or stem cell transplantation for eligible patients Clinical trials exploring emerging therapies
Clinical Advice & FAQs
Billing Guidance
Is D46.Z a billable ICD-10 code?
Yes, D46.Z is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D46.Z?
Clinical documentation must specify the nature of Other myelodysplastic syndromes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference